Non-neurotoxic activity of Malayan krait (Bungarus candidus) venom from Thailand

作者: Mongkon Charoenpitakchai , Kulachet Wiwatwarayos , Nattapon Jaisupa , Muhamad Rusdi Ahmad Rusmili , Supachoke Mangmool

DOI: 10.1186/S40409-018-0146-Y

关键词: MyotoxinVenomPharmacologyBungarusBiologyLactate dehydrogenaseBungarus candidusCreatine kinaseCytotoxicityNephrotoxicity

摘要: Envenoming by kraits (genus Bungarus) is a medically significant issue in South Asia and Southeast Asia. Malayan krait (Bungarus candidus) venom known to contain highly potent neurotoxins. In recent years, there have been reports on the non-neurotoxic activities of that include myotoxicity nephrotoxicity. However, research such non-neurotoxicity extremely limited. Thus, aim present study was determine myotoxic, cytotoxic nephrotoxic B. candidus venoms from northeastern (BC-NE) southern (BC-S) Thailand experimentally envenomed rats. Rats were administered (BC-NE or BC-S) (50 μg/kg, i.m.) 0.9% NaCl solution (50 μL, into right hind limb. The animals sacrificed 3, 6 24 h after administration. gastrocnemius muscle both kidneys collected for histopathological analysis. Blood samples also taken determination creatine kinase (CK) lactate dehydrogenase (LDH) levels. human embryonic kidney cell line (HEK-293) used cell proliferation assay activity. Administration BC-NE BC-S caused time-dependent myotoxicity, characterized an elevation CK LDH Histopathological examination skeletal displayed marked necrosis myofiber disintegration following Both induced extensive renal tubular injury with glomerular interstitial congestion (100–0.2 μg/mL) concentration-dependent cytotoxicity on the HEK-293 line. (IC50 = 8 ± 1 μg/mL; at incubation; n = 4) found be significantly more than (IC50 = 15 2 n = 4). addition, PLA2 activity higher venom. This populations possess activities. These findings may aid clinical diagnosis treatment patients future.

参考文章(41)
Narongsak Chaiyabutr, Taksa Vasaruchapong, Lawan Chanhome, Anudep Rungsipipat, Visith Sitprija, Acute effect of Russell’s viper (Daboia siamensis) venom on renal tubular handling of sodium in isolated rabbit kidney Asian Biomedicine. ,vol. 8, pp. 195- 202 ,(2014) , 10.5372/1905-7415.0802.279
P Gopalakrishnakone, D Ponraj, ESTABLISHMENT OF AN ANIMAL MODEL FOR MYOGLOBINURIA BY USE OF A MYOTOXIN FROM PSEUDECHIS AUSTRALIS (KING BROWN SNAKE) VENOM IN MICE Laboratory Animal Science. ,vol. 46, pp. 393- 398 ,(1996)
Adolfo Rafael de Roodt, Néstor Rubén Lago, Roberto Pablo Stock, Myotoxicity and nephrotoxicity by Micrurus venoms in experimental envenomation. Toxicon. ,vol. 59, pp. 356- 364 ,(2012) , 10.1016/J.TOXICON.2011.11.009
A.J. Hart, W. C. Hodgson, M. O’Leary, G. K. Isbister, Pharmacokinetics and pharmacodynamics of the myotoxic venom of Pseudechis australis (mulga snake) in the anesthetised rat. Clinical Toxicology. ,vol. 52, pp. 604- 610 ,(2014) , 10.3109/15563650.2014.914526
José María Gutiérrez, Luis Alberto Ponce-Soto, Sergio Marangoni, Bruno Lomonte, Systemic and local myotoxicity induced by snake venom group II phospholipases A2: comparison between crotoxin, crotoxin B and a Lys49 PLA2 homologue. Toxicon. ,vol. 51, pp. 80- 92 ,(2008) , 10.1016/J.TOXICON.2007.08.007
C. I. Johnston, S. G. A. Brown, M. A. O’Leary, B. J. Currie, R. Greenberg, M. Taylor, C. Barnes, J. White, G. K. Isbister, , Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy – Australian Snakebite Project (ASP-19) Clinical Toxicology. ,vol. 51, pp. 417- 424 ,(2013) , 10.3109/15563650.2013.787535
Andrew J. Hart, A. Ian Smith, Shane Reeve, Wayne C. Hodgson, Isolation and characterisation of acanmyotoxin-2 and acanmyotoxin-3, myotoxins from the venom of the death adder Acanthophis sp. Seram. Biochemical Pharmacology. ,vol. 70, pp. 1807- 1813 ,(2005) , 10.1016/J.BCP.2005.09.017